Hypoxia--a key regulatory factor in tumour growth - PubMed (original) (raw)
Review
doi: 10.1038/nrc704.
Affiliations
- PMID: 11902584
- DOI: 10.1038/nrc704
Review
Hypoxia--a key regulatory factor in tumour growth
Adrian L Harris. Nat Rev Cancer. 2002 Jan.
Abstract
Cells undergo a variety of biological responses when placed in hypoxic conditions, including activation of signalling pathways that regulate proliferation, angiogenesis and death. Cancer cells have adapted these pathways, allowing tumours to survive and even grow under hypoxic conditions, and tumour hypoxia is associated with poor prognosis and resistance to radiation therapy. Many elements of the hypoxia-response pathway are therefore good candidates for therapeutic targeting.
Similar articles
- Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis.
Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, Keshert E. Carmeliet P, et al. Nature. 1998 Jul 30;394(6692):485-90. doi: 10.1038/28867. Nature. 1998. PMID: 9697772 - Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression.
Makino Y, Cao R, Svensson K, Bertilsson G, Asman M, Tanaka H, Cao Y, Berkenstam A, Poellinger L. Makino Y, et al. Nature. 2001 Nov 29;414(6863):550-4. doi: 10.1038/35107085. Nature. 2001. PMID: 11734856 - [Hypoxia and tumors: does HIF-1 transcription factor favor tumor growth or hypoxia?].
Vandenbunder B. Vandenbunder B. Bull Cancer. 1998 Oct;85(10):843-5. Bull Cancer. 1998. PMID: 9835861 Review. French. - [The hypoxia-inducible factor HIF as a new target in cancer research].
L'Allemain G. L'Allemain G. Bull Cancer. 2002 Mar;89(3):257-60. Bull Cancer. 2002. PMID: 11940464 Review. French.
Cited by
- Hypoxia-induced DTL promotes the proliferation, metastasis, and sorafenib resistance of hepatocellular carcinoma through ubiquitin-mediated degradation of SLTM and subsequent Notch pathway activation.
Chen ZX, Mu MY, Yang G, Qi H, Fu XB, Wang GS, Jiang WW, Huang BJ, Gao F. Chen ZX, et al. Cell Death Dis. 2024 Oct 9;15(10):734. doi: 10.1038/s41419-024-07089-4. Cell Death Dis. 2024. PMID: 39384740 - Aberrant cytoplasmic expression of UHRF1 restrains the MHC-I-mediated anti-tumor immune response.
Tan L, Yin T, Xiang H, Wang L, Mudgal P, Chen J, Ding Y, Wang G, Lim BJW, Huang Y, Huang D, Liang Y, Alexander PB, Xiang K, Wang E, Yan C, Ma Z, Tan M, Li QJ, Wang XF. Tan L, et al. Nat Commun. 2024 Oct 3;15(1):8569. doi: 10.1038/s41467-024-52902-5. Nat Commun. 2024. PMID: 39362877 Free PMC article. - Hypoxic Signaling Is Modulated by Calcium Channel, CaV1.3, in Androgen-Resistant Prostate Cancer.
O'Reilly D, Buchanan PJ. O'Reilly D, et al. Bioelectricity. 2022 May 26;4(2):81-91. doi: 10.1089/bioe.2022.0007. eCollection 2022 May. Bioelectricity. 2022. PMID: 39350777 Free PMC article. - Tumor Hypoxia on 18F-fluoromisonidazole Positron Emission Tomography and Distant Metastasis From Head and Neck Squamous Cell Carcinoma.
Gui C, Wray R, Schöder H, Deasy JO, Grkovski M, Humm JL, Wong RJ, Sherman EJ, Riaz N, Lee NY. Gui C, et al. JAMA Netw Open. 2024 Sep 3;7(9):e2436407. doi: 10.1001/jamanetworkopen.2024.36407. JAMA Netw Open. 2024. PMID: 39348119 Free PMC article. - Analysis of High-Dose Ascorbate-Induced Cytotoxicity in Human Glioblastoma Cells and the Role of Dehydroascorbic Acid and Iron.
Piotrowsky A, Burkard M, Hammerschmidt K, Ruple HK, Nonnenmacher P, Schumacher M, Leischner C, Berchtold S, Marongiu L, Kufer TA, Lauer UM, Renner O, Venturelli S. Piotrowsky A, et al. Antioxidants (Basel). 2024 Sep 10;13(9):1095. doi: 10.3390/antiox13091095. Antioxidants (Basel). 2024. PMID: 39334754 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources